Population‐based patient‐reported quality of life outcomes following low‐dose‐rate versus high‐dose‐rate brachytherapy monotherapy for low‐intermediate risk …

WL Ong, M Evans, N Papa, S Williams… - Journal of Medical …, 2023 - Wiley Online Library
Introduction To evaluate patient reported quality of life outcomes (QoL) following low‐dose‐
rate brachytherapy (LDR‐BT) and high‐dose‐rate brachytherapy (HDR‐BT) monotherapy …
相关文章

Population-based patient-reported quality of life outcomes following low-dose-rate versus high-dose-rate brachytherapy monotherapy for low-intermediate risk …

WL Ong, M Evans, N Papa… - Journal of medical …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction To evaluate patient reported quality of life outcomes (QoL) following low-dose-
rate brachytherapy (LDR-BT) and high-dose-rate brachytherapy (HDR-BT) monotherapy for …

Population-based patient-reported quality of life outcomes following low-dose-rate versus high-dose-rate brachytherapy monotherapy for low-intermediate risk …

WL Ong, M Evans, N Papa, S Williams… - Journal of Medical …, 2023 - europepmc.org
Methods The study comprised men with low-intermediate risk prostate cancer in the Prostate
Cancer Outcomes Registry Victoria (PCOR-Vic), who were treated with LDR-BT or HDR-BT …